| Name: | Clopidogrel Camphorsulfonate |
| Catalogue No. | VL31012 |
| CAS No. | 120202-68-8 |
| Molecular Formula | C26H32ClNO6S2 |
| Molecular Weight | 554.1 g/mol |
| Status | In-Stock |
| IUPAC Name | [(1R,4S)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic acid;methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate |
| Description | Clopidogrel Camphorsulfonate (CAS No: 120202-68-8) is a S-isomer of Clopidogrel. Clopidogrel is an ADP receptor antagonist that is evaluated for the limitation of atherosclerotic events consisting of myocardial infarction, ischaemic stroke, and vascular death in patients having atherosclerosis manifested by recent stroke, myocardial infarction, or peripheral vascular disease. |
| References | “Efficient Synthesis of (S)-(+)-Clopidogrel Bisulfate-Capped Silver Nanoparticles.” Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 2016, www.tandfonline.com/doi/abs/10.1080/15533174.2015.1137028. Jarvis, Blair, and Kerryn Simpson. “Clopidogrel.” Drugs, vol. 60, no. 2, Aug. 2000, pp. 347–77, https://doi.org/10.2165/00003495-200060020-00012. |
